We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Multicentre cohort study reports treatment outcomes of ropeginterferon alfa-2b in mycosis fungoides, highlighting potential therapeutic options for cutaneous T-cell lymphoma.
No takes yet. Share an insight, caveat, or question.
Nikolaou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: